1. An Approach to Integrated Safety Analyses from Clinical Studies

   • Gerd K. Rosenkranz

   Biostatistics 30 December 2010 Pages: 649 - 657

2. A Review of Methods and Applications of the ROC Curve in Clinical Trials

   • Ramesh V Kumar
   • Grace Maria Antony

   Biostatistics 30 December 2010 Pages: 659 - 671

3. Behavioral Intentions and Information-Seeking Behavior: A Comparison of Nonbranded versus Branded Direct-to-Consumer Prescription Advertisements

   • Brent L. Rollins
   • Karen King
   • Matthew Petri

   Medical Information 30 December 2010 Pages: 673 - 683

4. Medical Information Support of the Sales Force: An External and Internal Assessment

   • Ashish Advani
   • Christi Marsh
   • Laurel E. Ashworth

   Medical Information 30 December 2010 Pages: 685 - 691

5. Analysis of Questionnaire Data concerning Bar Codes Printed on Ampoule Labels

   • Masaomi Kimura
   • Hiroyuki Furukawa
   • Fumito Tsuchiya

   Medical Information 30 December 2010 Pages: 693 - 701

6. Interim Analysis: What Regulatory Affairs Professionals Need to Know

   • David Coutant

   Regulatory Affairs 30 December 2010 Pages: 703 - 712

7. Refinement of the Clinical Scenario Evaluation Framework for Assessment of Competing Development Strategies with an Application to Multiple Sclerosis

   • Tim Friede
   • Richard Nicholas
   • Jeremy Chataway

   Regulatory Affairs 30 December 2010 Pages: 713 - 718

8. A Contract Research Organization's Challenge: Validating Cutting-Edge Software for Imaging in Clinical Studies

   • Brenda K. Young
   • Dena Flamini
   • James Gimpel

   Regulatory Affairs 30 December 2010 Pages: 719 - 725

9. Enhancing Control of the Medication Supply Chain in Clinical Trials Managed by Interactive Voice Response Systems

   • Sarah Waters
   • Iain Dowlman
   • Damian McEntegart

   Regulatory Affairs 30 December 2010 Pages: 727 - 740

10. Biosimilars in the EU: Nonclinical and Early Clinical Development

    • Emmanuelle Voisin
    • David Uguen
    • Marie Deneux

    Regulatory Affairs 30 December 2010 Pages: 741 - 743

11. Risk-Based Source Data Verification Approaches: Pros and Cons

    • Vadim Tantsyura
    • Imogene Grimes
    • Barbara Tardiff

    Regulatory Affairs 30 December 2010 Pages: 745 - 756

12. Globalization Facilitates Pediatric Drug Development in the 21 st Century

    • Julia Dunne
    • Lala Margaryants
    • William J. Rodriguez

    Clinical Trials 30 December 2010 Pages: 757 - 765